Q&A

An Interview With Dr. Albert Kim On Simulation-Guided Design

Source: Cytel
technology

Simulation-guided clinical trial design can help sponsors select the best path forward, harnessing data to forecast risks, navigate uncertainties, align on goals, and produce pressure-tested clinical trial designs. In the following interview, Cytel’s Chief Medical Officer Dr. Albert Kim speaks with Dr. Esha Senchaudhuri to discuss many aspects of simulation-guided design – its abilities, its benefits, and so much more.   

access the Q&A!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Cytel